Trial Profile
Efficacy of mepolizumab in patients with eosinophilic chronic obstructive pulmonary disease: A retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Jul 2018
Price :
$35
*
At a glance
- Drugs Mepolizumab (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 12 Jul 2018 New trial record
- 23 May 2018 Results presented at the 114th International Conference of the American Thoracic Society